Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1987-9-23
pubmed:abstractText
Mutant human beta-actin genes were introduced into normal human (KD) fibroblasts and the derivative cell line HuT-12, which is immortalized but nontumorigenic, to test their ability to promote conversion to the tumorigenic state. Transfected substrains of HuT-12 fibroblasts that expressed abundant levels of mutant beta-actin (Gly-244----Asp-244) produced subcutaneous tumors in athymic mice after long latent periods (1.5 to 3 months). However, transfected substrains of KD fibroblasts retained their normal finite life span in culture and consequently were incapable of producing tumors. Substrains of HuT-12 cells transfected with the wild-type beta-actin gene and some transfected strains that expressed low or undetectable levels of mutant beta-actin did not produce tumors. Cell lines derived from transfectant cell tumors always exhibited elevated synthesis of the mutant beta-actin, ranging from 145 to 476% of the level expressed by the transfected cells that were inoculated to form the tumor. In general, primary transfectant cells that expressed the highest levels of mutant beta-actin were more tumorigenic than strains that expressed lower levels. The tumor-derived strains were stable in tumorigenicity and produced tumors with shortened latent periods of only 2 to 4 weeks. These findings imply that the primary transfectant strains develop subpopulations of cells that are selected to form tumors because of their elevated rate of exogenous mutant beta-actin synthesis. Actin synthesis and accumulation of gamma-actin mRNA from the endogenous beta- and gamma-actin genes were diminished in tumor-derived strains, apparently to compensate for elevated mutant beta-actin synthesis and maintain the normal cellular concentration of actin. Synthesis of the transformation-sensitive tropomyosin isoforms was decreased along with mutant beta-actin expression. Such modulations in tropomyosin synthesis are characteristically seen in transformation of avian, rodent, and human fibroblasts. Our results suggest that this mutant beta-actin contributes to the neoplastic phenotype of immortalized human fibroblasts by imposing a cytoarchitectural defect and inducing abnormal expression of cytoskeletal tropomyosins.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-165499, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-2869410, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-2996000, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-3460482, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-3614198, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-3785208, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-3837182, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-3859366, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-4000123, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-4033781, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-4053036, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-4055761, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-418410, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6092933, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6095033, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6201399, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6272310, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6290897, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6293052, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6304115, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6315714, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6318314, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6332316, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6352074, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6646124, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6722823, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6892569, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6893954, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-6966280, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-7067038, http://linkedlifedata.com/resource/pubmed/commentcorrection/3614199-7199389
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0270-7306
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2467-76
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Expression of transfected mutant beta-actin genes: transitions toward the stable tumorigenic state.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't